<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03944863</url>
  </required_header>
  <id_info>
    <org_study_id>Antibiotic Prophylaxis POEM</org_study_id>
    <nct_id>NCT03944863</nct_id>
  </id_info>
  <brief_title>Impact of Antibiotic Prophylaxis in Per-oral Endoscopic Myotomy for Esophageal Motor Disorders</brief_title>
  <official_title>Impact of Antibiotic Prophylaxis and Conditioning Modalities in Per Oral Endoscopic Myotomy for Esophageal Motor Disorders</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Société Française d'Endoscopie Digestive</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Société Française d'Endoscopie Digestive</source>
  <oversight_info>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      No recommendation regarding antibiotic prophylaxis and preparation modalities are available
      for patients with esophageal motor disorders who benefit from Per-Oral Endoscopic Myotomy
      (POEM). The aim of our study was to evaluate the impact of antibiotic prophylaxis on the
      POEM's safety.

      This study was a comparative and multicentric retrospective analysis of a database
      prospectively maintained. Patients over 18 year's old with esophageal motor disorders
      confirmed by prior manometry, who underwent POEM were included. The primary endpoint was the
      occurrence of complications, as classified by Cotton, based on whether or not antibiotic
      prophylaxis was administered.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>December 2013</start_date>
  <completion_date type="Actual">June 30, 2018</completion_date>
  <primary_completion_date type="Actual">June 30, 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>The occurence of postoperative complications, according to Cotton's classification</measure>
    <time_frame>7 Days</time_frame>
    <description>Depending on whether or not antibiotic prophylaxis was administered</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>The evaluation of the efficacy of the procedure</measure>
    <time_frame>1 Month</time_frame>
    <description>According to the Eckard score</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The occurence of perioperative and postoperative complications</measure>
    <time_frame>7 Days</time_frame>
    <description>According to Cotton's classification</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The C-Reactive Protein and white blood cells count sampled</measure>
    <time_frame>1 Day</time_frame>
    <description>Blood test the day after the procedure, level of CRP in mg/L</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">252</enrollment>
  <condition>Esophagus Disorder</condition>
  <condition>Esophageal Achalasia</condition>
  <arm_group>
    <arm_group_label>POEM + Antibiotic prophylaxis</arm_group_label>
    <description>Cefazolin: 2g or Amoxicillin - clavulanic acid: 1g x 3 during 7 days</description>
  </arm_group>
  <arm_group>
    <arm_group_label>POEM + No antibiotic prophylaxis</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Antibiotics</intervention_name>
    <arm_group_label>POEM + Antibiotic prophylaxis</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Adults patients presenting a major esophageal motor disorder confirmed by prior manometry
        according to the Chicago classification and treated by per-oral endoscopic myotomy after a
        multidisciplinary meeting decision. Under-age patients were excluded.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Adults patients presenting a major esophageal motor disorder confirmed by prior
             manometry according to the Chicago classification and treated by per-oral endoscopic
             myotomy after a multidisciplinary meeting decision

        Exclusion Criteria:

          -  Under-age patients were excluded
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <verification_date>May 2019</verification_date>
  <study_first_submitted>May 6, 2019</study_first_submitted>
  <study_first_submitted_qc>May 7, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">May 10, 2019</study_first_posted>
  <last_update_submitted>May 7, 2019</last_update_submitted>
  <last_update_submitted_qc>May 7, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">May 10, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Société Française d'Endoscopie Digestive</investigator_affiliation>
    <investigator_full_name>VANBIERVLIET</investigator_full_name>
    <investigator_title>Medical Doctor,Physician Doctor, Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>antibiotic prophylaxis</keyword>
  <keyword>per oral endoscopic myotomy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Esophageal Achalasia</mesh_term>
    <mesh_term>Esophageal Diseases</mesh_term>
    <mesh_term>Esophageal Motility Disorders</mesh_term>
    <mesh_term>Esophageal Spasm, Diffuse</mesh_term>
    <mesh_term>Motor Disorders</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anti-Bacterial Agents</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

